These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 20735469)

  • 41. Mitochondria and Parkinson's Disease: Clinical, Molecular, and Translational Aspects.
    Borsche M; Pereira SL; Klein C; Grünewald A
    J Parkinsons Dis; 2021; 11(1):45-60. PubMed ID: 33074190
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Molecular changes in the postmortem parkinsonian brain.
    Toulorge D; Schapira AH; Hajj R
    J Neurochem; 2016 Oct; 139 Suppl 1():27-58. PubMed ID: 27381749
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Crosstalk of organelles in Parkinson's disease - MiT family transcription factors as central players in signaling pathways connecting mitochondria and lysosomes.
    Lang M; Pramstaller PP; Pichler I
    Mol Neurodegener; 2022 Jul; 17(1):50. PubMed ID: 35842725
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Mitochondrial homeostasis: the interplay between mitophagy and mitochondrial biogenesis.
    Palikaras K; Tavernarakis N
    Exp Gerontol; 2014 Aug; 56():182-8. PubMed ID: 24486129
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Impaired mitochondrial-endoplasmic reticulum interaction and mitophagy in Miro1-mutant neurons in Parkinson's disease.
    Berenguer-Escuder C; Grossmann D; Antony P; Arena G; Wasner K; Massart F; Jarazo J; Walter J; Schwamborn JC; Grünewald A; Krüger R
    Hum Mol Genet; 2020 May; 29(8):1353-1364. PubMed ID: 32280985
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Dissecting the role of the mitochondrial chaperone mortalin in Parkinson's disease: functional impact of disease-related variants on mitochondrial homeostasis.
    Burbulla LF; Schelling C; Kato H; Rapaport D; Woitalla D; Schiesling C; Schulte C; Sharma M; Illig T; Bauer P; Jung S; Nordheim A; Schöls L; Riess O; Krüger R
    Hum Mol Genet; 2010 Nov; 19(22):4437-52. PubMed ID: 20817635
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Mitochondrial dysfunction in Parkinson's disease: molecular mechanisms and pathophysiological consequences.
    Exner N; Lutz AK; Haass C; Winklhofer KF
    EMBO J; 2012 Jun; 31(14):3038-62. PubMed ID: 22735187
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Mitochondrial damages and Parkinson's disease.
    Imai Y
    Nihon Rinsho; 2017 Jan; 75(1):28-35. PubMed ID: 30566291
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Knockdown of Hsc70-5/mortalin induces loss of synaptic mitochondria in a Drosophila Parkinson's disease model.
    Zhu JY; Vereshchagina N; Sreekumar V; Burbulla LF; Costa AC; Daub KJ; Woitalla D; Martins LM; Krüger R; Rasse TM
    PLoS One; 2013; 8(12):e83714. PubMed ID: 24386261
    [TBL] [Abstract][Full Text] [Related]  

  • 50. New insights on the mitochondrial proteome plasticity in Parkinson's disease.
    Aroso M; Ferreira R; Freitas A; Vitorino R; Gomez-Lazaro M
    Proteomics Clin Appl; 2016 Apr; 10(4):416-29. PubMed ID: 26749507
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Changes of mitochondrial dynamics as a response to mitochondrial stress in models of sporadic Parkinson's disease].
    Partyka M; Duszyński J; Szczepanowska J
    Postepy Biochem; 2016; 62(2):173-181. PubMed ID: 28132469
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Mitochondrial metabolism in Parkinson's disease impairs quality control autophagy by hampering microtubule-dependent traffic.
    Arduíno DM; Esteves AR; Cortes L; Silva DF; Patel B; Grazina M; Swerdlow RH; Oliveira CR; Cardoso SM
    Hum Mol Genet; 2012 Nov; 21(21):4680-702. PubMed ID: 22843496
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Mitochondrial Dysfunction in Parkinson's Disease: New Mechanistic Insights and Therapeutic Perspectives.
    Park JS; Davis RL; Sue CM
    Curr Neurol Neurosci Rep; 2018 Apr; 18(5):21. PubMed ID: 29616350
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Crosstalk between mitochondrial (dys)function and mitochondrial abundance.
    Michel S; Wanet A; De Pauw A; Rommelaere G; Arnould T; Renard P
    J Cell Physiol; 2012 Jun; 227(6):2297-310. PubMed ID: 21928343
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Mitochondrial dysfunction and oxidative stress in Parkinson's disease and monogenic parkinsonism.
    Hauser DN; Hastings TG
    Neurobiol Dis; 2013 Mar; 51():35-42. PubMed ID: 23064436
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Dietary Macronutrient Management to Treat Mitochondrial Dysfunction in Parkinson's Disease.
    Bajracharya R; Youngson NA; Ballard JWO
    Int J Mol Sci; 2019 Apr; 20(8):. PubMed ID: 30991634
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Mitochondrial and Organellar Crosstalk in Parkinson's Disease.
    Ray B; Bhat A; Mahalakshmi AM; Tuladhar S; Bishir M; Mohan SK; Veeraraghavan VP; Chandra R; Essa MM; Chidambaram SB; Sakharkar MK
    ASN Neuro; 2021; 13():17590914211028364. PubMed ID: 34304614
    [TBL] [Abstract][Full Text] [Related]  

  • 58. New insights into the complex role of mitochondria in Parkinson's disease.
    Grünewald A; Kumar KR; Sue CM
    Prog Neurobiol; 2019 Jun; 177():73-93. PubMed ID: 30219247
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Bioenergetics and Autophagic Imbalance in Patients-Derived Cell Models of Parkinson Disease Supports Systemic Dysfunction in Neurodegeneration.
    González-Casacuberta I; Juárez-Flores DL; Morén C; Garrabou G
    Front Neurosci; 2019; 13():894. PubMed ID: 31551675
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Quality Control in Neurons: Mitophagy and Other Selective Autophagy Mechanisms.
    Evans CS; Holzbaur ELF
    J Mol Biol; 2020 Jan; 432(1):240-260. PubMed ID: 31295455
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.